therapy
therapeutical
prognostic
prognosis
recurrence-free survival
recurrence-free
chemoterapy
chemoterapeutical
prognosis
disease-free survival
disease-free
precision medicine
response
treatment
prevention
target therapy
target
targeted therapy
targeted
proliferation
inhibition
inhibitor
outcome
TNM
PFS
DFS
cell line
represses
case report
OS
overall survival
personalized medicine strategy
resistance
risk
metastasis
stage
Gleason
grade
grading
recurrence
antitumor
malignancy
meta-analysis
progression
model
in vivo
existing drugs
drugs
agressive
risk stratification
chemoradiotherapy
radiotherapy
cisplatin
efficacy
efficiency
sensitive
trial
phase I
phasse II
clinical trial
clinical
placebo-controlled
oral inhibitor
potent
first-in-class
RFS
relapse-free survival
relapse-free
smoking
trastuzumab
capecitabine
overview
overexpression
amplification
tumor
tumour
cancer
cancers
carcinoma
carcinomas
neoplasm
neoplasms
surgery